Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [520]
News [1466]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
ECC 2013 Preview: Scientific programme highlights
Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013
Treatment of melanoma in Latin America
Dr Alessandro Testori - European Institute of Oncology, Milan, Italy
Treatment of melanoma in Latin America ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )
9 Jul 2013
Vemurafenib and ipilimumab for metastatic melanoma
Dr Caroline Robert - Institute Gustave Roussy, Paris, France
Vemurafenib and ipilimumab for metastatic melanoma ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France )
14 Jun 2013
Role of microenvironment and stroma in cancer therapy
Dr Stephen Ansell - Mayo Clinic, Rochester, USA
Role of microenvironment and stroma in cancer therapy ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )
7 Jun 2013
Science behind phase I clinical trials: targeting tumour cell development...
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
ASCO 2013 highlights
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
Phase I study measures effect of ipilimumab and nivolumab combination in...
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Phase I study measures effect of ipilimumab and nivolumab combination in melanoma patients ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab
Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
3 Jun 2013
Nivolumab blocking PD1 in lung cancer and melanoma
Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA
Nivolumab blocking PD1 in lung cancer and melanoma ( Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA )
3 Jun 2013
Selumetinib, the first effective drug for advanced melanoma of the eye
Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA
Selumetinib, the first effective drug for advanced melanoma of the eye ( Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA )
3 Jun 2013
Ipilimumab and BRAF inhibitors for advanced melanoma
Dr Lynn Schuchter - University of Pennsylvania, USA
Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )
2 Jun 2013
PDL1 inhibitors in melanoma
Dr Roy Herbst - Yale Cancer Center, New Haven, USA
PDL1 inhibitors in melanoma ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
2 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation